Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mismatch Repair01:20

Mismatch Repair

4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K
Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
Metastasis02:30

Metastasis

5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

When does additional information improve accuracy of RNA secondary structure prediction?

bioRxiv : the preprint server for biology·2026
Same author

When Does Additional Information Improve Accuracy of RNA Secondary Structure Prediction?

Journal of chemical information and modeling·2025
Same author

Single-cell profiling of EZH2-mediated immune signaling perturbations in NSCLC.

bioRxiv : the preprint server for biology·2025
Same author

Modular Control of Boolean Network Models.

Bulletin of mathematical biology·2025
Same author

Canalization reduces the nonlinearity of regulation in biological networks.

NPJ systems biology and applications·2024
Same author

Pancreatic cancer mutationscape: revealing the link between modular restructuring and intervention efficacy amidst common mutations.

bioRxiv : the preprint server for biology·2024

Related Experiment Video

Updated: Jun 21, 2025

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

11.1K

Cancer mutationscape: revealing the link between modular restructuring and intervention efficacy among mutations.

Daniel Plaugher1, David Murrugarra2

  • 1Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY, USA. plaugher_dr@uky.edu.

NPJ Systems Biology and Applications
|July 13, 2024
PubMed
Summary

Biological systems exhibit modularity. This study links the structure of pancreatic cancer (PC) signaling networks to disease behavior and treatment efficacy, revealing how mutations impact modularity and influence therapeutic strategies.

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.6K
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.3K

Related Experiment Videos

Last Updated: Jun 21, 2025

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

11.1K
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.6K
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.3K

Area of Science:

  • Systems biology
  • Computational biology
  • Cancer research

Background:

  • Biological systems, including gene regulatory networks (GRNs), exhibit modular structures and functions.
  • These complex networks are hierarchically organized and dynamically regulate cellular processes and cell fate.
  • Understanding the interplay between structure and function in disease networks is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the relationship between the modular structure of pancreatic cancer (PC) signaling networks and their function.
  • To determine how mutations affect the modularity of PC networks and influence disease aggression and controllability.
  • To explore the correlation between mutation impact/location and the efficacy of single-agent treatments in silico.

Main Methods:

  • Utilized a stochastic multicellular signaling network model of pancreatic cancer (PC).
  • Analyzed the variance in topological rankings of phenotypically influential modules.
  • Simulated the effects of mutations on modular structure and disease characteristics in silico.

Main Results:

  • The variance in topological rankings of influential modules strongly correlates with the structure-function relationship in PC networks.
  • Mutations alter the modular structure, impacting the in silico aggression and controllability of pancreatic cancer.
  • Mutation impact and location relative to PC modular structure predict the efficacy of single-agent treatments in silico.

Conclusions:

  • The modular architecture of biological signaling networks is intrinsically linked to their function.
  • Targeting mutations within the modular structure of pancreatic cancer networks is essential for effective therapeutic control.
  • Topologically deep mutations necessitate deep-seated targets for successful in silico treatment strategies.